Penn Medicine Provider
Pulmonary Medicine
Namrata B. Patel, MD
5.0
(292)
Accepting new patients
Sees patients age 18 and up
Harron Lung Center Perelman

About me

  • Clinical Director, Interstitial Lung Disease Program
  • Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)

Education and training

  • Medical School: University of Maryland School of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Temple University Hospital

What my patients think about me

Average Rating
5.0

292 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
saved my life
April 2025
5.0
5.0
really supportive
April 2025
5.0
5.0
dr. patel is extremely thorough and personable- she asked many probing questions pertaining to my health- she is very knowledgeable and very caring. couldn't ask for a better doctor.
April 2025
5.0
5.0
she is through and straight forward. answers all questions.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Patel is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Courtwright, Andrew, Namrata Patel, Anil Chandraker, and Hilary J Goldberg. Human leukocyte antigen antibody sensitization, lung transplantation, and health equity. , American Journal of Transplantation, 22(3): 2022,698-704


Namrata Patel "What is Familial IPF?" , Podcast, PA-IPF: 2022


Courtwright AM, Kamoun M, Diamond JM, Kearns J, Ahya VN, Christie JD, Clausen E, Hadjiliadis D, Patel N, Salgado JC, Cevasco M, Cantu EE, Crespo MM, Bermudez CA. Lung transplantation outcomes after crossing low-level donor specific antibodies without planned augmented immunosuppression , Clin Transplant, 35(11): 2021,e14447


Vahdatpour CA, Pichler A, Palevsky HI, Kallan MJ, Patel NB, Kinniry PA. Interstitial Lung Disease Associated Acute Respiratory Failure Requiring Invasive Mechanical Ventilation: A Retrospective Analysis , Open Respir Med J, 14: 2020,67-77


Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Va��v�, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, et al. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis , Am J Respir Crit Care Med, 200: 2019,199-208


Courtwright AM, Zaleski D, Gardo L, Ahya VN, Christie JD, Crespo M, Hadjiliadis D, Lee J, Molina M, Patel N, Porteous M, Cantu EE, Bermudez C, Diamond JM. Causes, Preventability, and Cost of Unplanned Rehospitalizations Within 30 Days of Discharge After Lung Transplantation. , Transplantation., 102(5): 2018,838-844


Courtwright AM, Zaleski D, Gardo L, Ahya VN, Christie JD, Crespo M, Hadjiliadis D, Lee J, Molina M, Patel N, Porteous M, Cantu EE, Bermudez C, Diamond JM. Causes, Preventability, and Cost of Unplanned Rehospitalizations Within 30 Days of Discharge After Lung Transplantation , Transplantation, 102(5): 2018,838-844


Patel Namrata B, Christie Jason D Alveolar Type 2 Cell Transplantation in IPF: Recreating the Silver Lining. , Chest, 150(3): 2016,481-2


Taghavi Sharven, Jayarajan Senthil N, Furuya Yuka, Komaroff Eugene, Shiose Akira, Leotta Eros, Hisamoto Kazuhiro, Patel Namrata, Cordova Francis, Criner Gerard, Guy T Sloane, Toyoda Yoshiya Examining ABO compatible donors in double lung transplants during the era of lung allocation score. , The Annals of thoracic surgery, 98(4): 2014,1167-74


Taghavi Sharven, Jayarajan Senthil N, Furuya Yuka, Komaroff Eugene, Shiose Akira, Leotta Eros, Hisamoto Kazuhiro, Patel Namrata, Cordova Francis, Criner Gerard, Guy T Sloane, Toyoda Yoshiya Single-lung transplantation with ABO-compatible donors results in excellent outcomes. , The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 33(8): 2014,822-8